REFERENCES
[1] Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N,
Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19
characteristics. Biol Proced Online. 2020 Aug 4;22:19. doi:
10.1186/s12575-020-00128-2. PMID: 32774178; PMCID: PMC7402395.
[2] Khachfe HH, Chahrour M, Sammouri J, Salhab H, Makki BE, Fares M.
An Epidemiological Study on COVID-19: A Rapidly Spreading Disease.
Cureus. 2020 Mar 18;12(3):e7313. doi: 10.7759/cureus.7313. PMID:
32313754; PMCID: PMC7164711.
[3] Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S,
Greenberg N, Rubin GJ. The psychological impact of quarantine and how to
reduce it: rapid review of the evidence. Lancet. 2020 Mar
14;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8. Epub 2020 Feb
26. PMID: 32112714; PMCID: PMC7158942.
[4] Neria Y, Nandi A, Galea S. Post-traumatic stress disorder
following disasters: a systematic review. Psychol Med. 2008
Apr;38(4):467-80. doi: 10.1017/S0033291707001353. Epub 2007 Sep 6. PMID:
17803838; PMCID: PMC4877688.
[5] Lee AM, Wong JG, McAlonan GM, Cheung V, Cheung C, Sham PC, Chu
CM, Wong PC, Tsang KW, Chua SE. Stress and psychological distress among
SARS survivors 1 year after the outbreak. Can J Psychiatry. 2007
Apr;52(4):233-40. doi: 10.1177/070674370705200405. PMID: 17500304.
[6] Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate
Psychological Responses and Associated Factors during the Initial Stage
of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General
Population in China. Int J Environ Res Public Health. 2020 Mar
6;17(5):1729. doi: 10.3390/ijerph17051729. PMID: 32155789; PMCID:
PMC7084952.
[7] Choi EPH, Hui BPH, Wan EYF. Depression and Anxiety in Hong Kong
during COVID-19. Int J Environ Res Public Health. 2020 May
25;17(10):3740. doi: 10.3390/ijerph17103740. PMID: 32466251; PMCID:
PMC7277420.
[8] Zhou SJ, Zhang LG, Wang LL, Guo ZC, Wang JQ, Chen JC, Liu M,
Chen X, Chen JX. Prevalence and socio-demographic correlates of
psychological health problems in Chinese adolescents during the outbreak
of COVID-19. Eur Child Adolesc Psychiatry. 2020 Jun;29(6):749-758. doi:
10.1007/s00787-020-01541-4. Epub 2020 May 3. PMID: 32363492; PMCID:
PMC7196181.
[9] Zhang W, Yang X, Zhao J, Yang F, Jia Y, Cui C, Yang X.
Depression and Psychological-Behavioral Responses Among the General
Public in China During the Early Stages of the COVID-19 Pandemic: Survey
Study. J Med Internet Res. 2020 Sep 4;22(9):e22227. doi: 10.2196/22227.
PMID: 32886066; PMCID: PMC7501583.
[10] Bäuerle A, Teufel M, Musche V, Weismüller B, Kohler H, Hetkamp
M, Dörrie N, Schweda A, Skoda EM. Increased generalized anxiety,
depression and distress during the COVID-19 pandemic: a cross-sectional
study in Germany. J Public Health (Oxf). 2020 Nov 23;42(4):672-678. doi:
10.1093/pubmed/fdaa106. PMID: 32657323; PMCID: PMC7454766.
[11] Bäuerle A, Steinbach J, Schweda A, Beckord J, Hetkamp M,
Weismüller B, Kohler H, Musche V, Dörrie N, Teufel M, Skoda EM. Mental
Health Burden of the COVID-19 Outbreak in Germany: Predictors of Mental
Health Impairment. J Prim Care Community Health. 2020
Jan-Dec;11:2150132720953682. doi: 10.1177/2150132720953682. PMID:
32865107; PMCID: PMC7457643.
[12] Graziano S, Spanò B, Majo F, Righelli D, Vincenzina L, Quittner
A, Tabarini P. Rates of depression and anxiety in Italian patients with
cystic fibrosis and parent caregivers: Implementation of the Mental
Health Guidelines. Respir Med. 2020 Oct;172:106147. doi:
10.1016/j.rmed.2020.106147. Epub 2020 Sep 10. PMID: 32961510.
[13] Quittner AL, Goldbeck L, Abbott J, Duff A, Lambrecht P, Solé A,
Tibosch MM, Bergsten Brucefors A, Yüksel H, Catastini P, Blackwell L,
Barker D. Prevalence of depression and anxiety in patients with cystic
fibrosis and parent caregivers: results of The International Depression
Epidemiological Study across nine countries. Thorax. 2014
Dec;69(12):1090-7. doi: 10.1136/thoraxjnl-2014-205983. Epub 2014 Sep 21.
PMID: 25246663.
[14] Radtke T, Haile SR, Dressel H, Benden C. Recommended shielding
against COVID-19 impacts physical activity levels in adults with cystic
fibrosis. J Cyst Fibros. 2020 Nov;19(6):875-879. doi:
10.1016/j.jcf.2020.08.013. Epub 2020 Aug 28. PMID: 32878732; PMCID:
PMC7455146.
[15] Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B,
Hempstead SE, Marshall B, Sabadosa KA, Elborn S; International Committee
on Mental Health; EPOS Trial Study Group. International Committee on
Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and
European Cystic Fibrosis Society consensus statements for screening and
treating depression and anxiety. Thorax. 2016 Jan;71(1):26-34. doi:
10.1136/thoraxjnl-2015-207488. Epub 2015 Oct 9. PMID: 26452630; PMCID:
PMC4717439.
[16] Schechter MS, Ostrenga JS, Fink AK, Barker DH, Sawicki GS,
Quittner AL. Decreased survival in cystic fibrosis patients with a
positive screen for depression. J Cyst Fibros. 2020 Aug
12:S1569-1993(20)30812-2. doi: 10.1016/j.jcf.2020.07.020. Epub ahead of
print. PMID: 32800486.
[17] Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent
N, de Soir E, Vos R, Dupont L. The impact of the COVID-19 pandemic on
the emotional well-being and home treatment of Belgian patients with
cystic fibrosis, including transplanted patients and paediatric
patients. J Cyst Fibros. 2020 Nov;19(6):880-887. doi:
10.1016/j.jcf.2020.07.022. Epub 2020 Jul 31. PMID: 32768311.
[18] Pınar Senkalfa B, Sismanlar Eyuboglu T, Aslan AT, Ramaslı
Gursoy T, Soysal AS, Yapar D, İlhan MN. Effect of the COVID-19 pandemic
on anxiety among children with cystic fibrosis and their mothers.
Pediatr Pulmonol. 2020 Aug;55(8):2128-2134. doi: 10.1002/ppul.24900.
Epub 2020 Jun 26. PMID: 32530552; PMCID: PMC7307121.
[19] Spitzer RL, Williams JB, Kroenke K, Hornyak R, McMurray J.
Validity and utility of the PRIME-MD patient health questionnaire in
assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient
Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol.
2000 Sep;183(3):759-69. doi: 10.1067/mob.2000.106580. PMID: 10992206.
[20] National Collaborating Center for Mental Health. Common Mental
Health Disorders: The NICE Guideline on identification and pathways to
care. Leicester, UK: The British Psychological Society & The Royal
College of Psychiatrists, 2011.
[21] Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a
brief depression severity measure. J Gen Intern Med. 2001
Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. PMID:
11556941; PMCID: PMC1495268.
[22] Manea L, Gilbody S, McMillan D. Optimal cut-off score for
diagnosing depression with the Patient Health Questionnaire (PHQ-9): a
meta-analysis. CMAJ. 2012 Feb 21;184(3):E191-6. doi:
10.1503/cmaj.110829. Epub 2011 Dec 19. PMID: 22184363; PMCID:
PMC3281183.
[23] Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for
assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006
May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092. PMID:
16717171.
[24] Hundt NE, Mignogna J, Underhill C, Cully JA. The relationship
between use of CBT skills and depression treatment outcome: a
theoretical and methodological review of the literature. Behav Ther.
2013 Mar;44(1):12-26. doi: 10.1016/j.beth.2012.10.001. Epub 2012 Oct 14.
PMID: 23312423.
[25] Tolin DF. Is cognitive-behavioral therapy more effective than
other therapies? A meta-analytic review. Clin Psychol Rev. 2010
Aug;30(6):710-20. doi: 10.1016/j.cpr.2010.05.003. Epub 2010 May 25.
PMID: 20547435.
[26] Friedman D. CF-CBT: A Cognitive-Behavioral Skills-Based Program
to Promote Emotional Well-Being for Adults with CF. Participant
workbook; Intervention manual for providers, unpublished, © 2019 The
General Hospital Corporation. All Rights Reserved.
[27] Järvholm S, Ericson P, Gilljam M. Patient acceptance and
outcome of mental health screening in Swedish adults with cystic
fibrosis. Qual Life Res. 2020 Jun;29(6):1579-1585. doi:
10.1007/s11136-020-02417-5. Epub 2020 Jan 9. PMID: 31919786; PMCID:
PMC7253508.
[28] Verkleij M, de Winter D, Hurley MA, Abbott J. Implementing the
International Committee on Mental Health in Cystic Fibrosis (ICMH)
guidelines: Screening accuracy and referral-treatment pathways. J Cyst
Fibros. 2018 Nov;17(6):821-827. doi: 10.1016/j.jcf.2018.02.005. Epub
2018 Mar 2. PMID: 29503039.